French Vasculitis Study Group   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Paris France (1981)

Organization Overview

First Clinical Trial
2008
NCT00647166
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

French Vasculitis Study Group | French Vasculitis Study Group (FVSG)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Churg-Strauss Syndrome (Phase 4)

Granulomatosis with Polyangiitis (Phase 4)

Microscopic Polyangiitis (Phase 3)

Polyarteritis Nodosa (Phase 3)

Systemic Vasculitis (Phase 4)

Vasculitis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 5